Two studies assessed beliefs and attitudes toward affirmative action in the workplace. Opposition to affirmative action was most strongly associated with respondent race (White) and political conservatism, the belief that it involves strong actions (preferential hiring and setting aside jobs), and the expectation that it will hurt company performance. Attitudes were also positively associated with perceived frequency of employment discrimination experienced by the target group and negatively associated with their resulting employment opportunities. Regression results revealed that economic consequences for the company overwhelmed beliefs about target group employment opportunities in predicting affirmative action attitudes. Respondents associated aftirmative action most strongly with Black and Hispanic targets, and White respondents whose affirmative action schemas featured these 2 targets had the most negative attitudes.
Further understanding of the schizophrenia spectrum has helped to define the prodrome of the illness, leading to hopes of earlier identification and intervention in susceptible, at-risk individuals. Given the heterogeneity and comorbidity observed in the clinically and demographically identified prodromal sample, it is essential that neurobiological markers that are more closely linked to brain function, and perhaps the ability to predict evolution of psychosis, be identified. Ultimately, it may be possible to identify an algorithm of risk factors that will combine clinical and demographic risk factors with vulnerability markers associated with later development of schizophrenia to better target at-risk individuals or preventative treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.